These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 21454988)
21. Impact of disturbances of calcium and phosphate metabolism on vascular calcification and clinical outcomes in patients with chronic kidney disease. Nikolov IG; Mozar A; Drüeke TB; Massy ZA Blood Purif; 2009; 27(4):350-9. PubMed ID: 19295198 [TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of vascular calcification in chronic kidney disease. Cozzolino M; Brancaccio D; Gallieni M; Slatopolsky E Kidney Int; 2005 Aug; 68(2):429-36. PubMed ID: 16014020 [TBL] [Abstract][Full Text] [Related]
23. High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression. Román-García P; Carrillo-López N; Fernández-Martín JL; Naves-Díaz M; Ruiz-Torres MP; Cannata-Andía JB Bone; 2010 Jan; 46(1):121-8. PubMed ID: 19772957 [TBL] [Abstract][Full Text] [Related]
25. [Vascular calcification and arteriosclerosis in chronic kidney disease patients]. Rodríguez Portillo JM Med Clin (Barc); 2009 May; 132 Suppl 1():43-7. PubMed ID: 19460480 [TBL] [Abstract][Full Text] [Related]
26. [Experimental study of the mechanism for vascular calcification in chronic kidney disease]. Persy V Verh K Acad Geneeskd Belg; 2008; 70(4):285-303. PubMed ID: 19166100 [TBL] [Abstract][Full Text] [Related]
27. Arterial calcification and stiffness in chronic kidney disease. Kerr PG; Guerin AP Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):683-7. PubMed ID: 17581230 [TBL] [Abstract][Full Text] [Related]
28. [Pathogenesis and therapy for vascular calcification in patients on chronic hemodialysis]. Nitta K Clin Calcium; 2005 Jul; 15(7):106-14. PubMed ID: 15995305 [TBL] [Abstract][Full Text] [Related]
29. [Management of hyperphosphatemia ; phosphate-binder]. Yokoyama K Clin Calcium; 2009 Feb; 19(2):205-12. PubMed ID: 19182360 [TBL] [Abstract][Full Text] [Related]
30. Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease. Raggi P; Kleerekoper M Clin J Am Soc Nephrol; 2008 May; 3(3):836-43. PubMed ID: 18322050 [TBL] [Abstract][Full Text] [Related]
35. The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease. Goodman WG Semin Dial; 2004; 17(3):209-16. PubMed ID: 15144547 [TBL] [Abstract][Full Text] [Related]
36. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Collin-Osdoby P Circ Res; 2004 Nov; 95(11):1046-57. PubMed ID: 15564564 [TBL] [Abstract][Full Text] [Related]
37. The role of vitamin D in vascular calcification in chronic kidney disease. Wolisi GO; Moe SM Semin Dial; 2005; 18(4):307-14. PubMed ID: 16076354 [TBL] [Abstract][Full Text] [Related]
38. Soft tissue calcifications in systemic disease. Dalinka MK; Melchior EL Bull N Y Acad Med; 1980; 56(6):539-63. PubMed ID: 6930311 [No Abstract] [Full Text] [Related]
39. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Bone metabolism in CKD-MBD]. Kazama JJ Clin Calcium; 2010 Jul; 20(7):1038-44. PubMed ID: 20585182 [TBL] [Abstract][Full Text] [Related]
40. [CKD-MBD (chronic kidney disease-mineral and bone disorder). CKD-MBD: chronic kidney disease-mineral and bone disorder]. Mizobuchi M; Aoshima Y; Akizawa T Clin Calcium; 2010 Jul; 20(7):995-1003. PubMed ID: 20585177 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]